• ORIGINAL ANALYSIS

  • PDF DOWNLOAD

  • EXTERNAL LINK

  • POST

prescription-drug

Featured Content

Prescription Drug: Legislation

Summary of Senate Finance Prescription Drug Package

July 24, 2019

Senate Finance Committee posts description of the Chairman’s mark of its legislation addressing prescription drug pricing.

The Latest from our Resource Centers

The Overlap of Drug Pricing Proposals

Insight: original analysis

The Overlap of Drug Pricing Proposals

September 20, 2019

On September 19, 2019, the Speaker of the US House of Representatives released a proposal to contain federal and individual spending on prescription drugs, joining Administration and Senate efforts to address prescription drug pricing. This article contemplates the likelihood of a drug pricing package and how it could come together.

ORIGINAL ANALYSIS

prescription-drug

Prescription Drug: Pricing

Administration Withdraws Rebate Overhaul Proposal

July 11, 2019

The Administration has announced it is no longer pursuing its drug pricing proposal that would have required pharmacy benefit managers to pass rebates directly on to the patient.

POST

prescription-drug

Prescription Drug: Litigation

Judge Axes Price Disclosure Rule for Drug Ads

July 09, 2019

  The Trump administration cannot force drug manufacturers to disclose prices in their pharmaceutical ads to consumers, a federal judge ruled Monday.  

EXTERNAL LINK

prescription-drug

Prescription Drug: Other

CMS Posts Agenda for June 24 CLFS Annual Public Meeting

July 09, 2019

On June 7, CMS posted the agenda for the annual public CLFS meeting.

POST

prescription-drug

Prescription Drug: Regulation

CMS Releases Final Part D Rule

May 17, 2019

On May 16, 2018, CMS released the final Part D and Medicare Advantage rule aimed at lowering drug prices.

POST

prescription-drug

Prescription Drug: Regulation

CMS Issues Final Rule on Drug Pricing Transparency

May 08, 2019

The Centers for Medicare and Medicaid Services (CMS) released the Final Rule on requiring list prices to be included in direct-to-consumer television advertisements for prescription drug that are reimbursable under Medicare or Medicaid. List price is defined as the wholesale acquisition cost (WAC) for a “typical 30-day regimen or for a typical course of treatment”…

EXTERNAL LINK

prescription-drug

Prescription Drug: Other

House Appropriations Releases Report Accompanying Appropriations Bill

May 08, 2019

The House Appropriations Committee released the Committee Report to accompany the Departments of Labor, Health and Human Services, Education and Related Agencies appropriations bill. Notably, the report includes strong language expressing concern related to the Administration’s proposal to change the six protected categories of drugs in Medicare Part D.

EXTERNAL LINK

prescription-drug

Prescription Drug: Pricing

House E&C Health Subcommittee to Hold Medicare Prescription Drug Cost Hearing

May 01, 2019

The House Energy and Commerce Health Subcommittee will hold a hearing on prescription drug costs in Medicare. Drug pricing continues to be a hot topic on Capitol Hill as lawmakers review several proposals to lower costs.

EXTERNAL LINK

prescription-drug

Prescription Drug: Legislation

House Judiciary Committee Marks Up Cost Reduction Bills

May 01, 2019

On Tuesday, April 30th, the House Judiciary Committee will mark-up several bills aimed at reducing the cost of prescription drugs. These bills are: H.R. 965, the “CREATES Act”; H.R. 2375, the “Preserve Access to Affordable Generics and Biosimilars Act”; H.R. 2374, the “Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act”; and…

EXTERNAL LINK

The First 100 Days: House Health Policy Recap

Insight: original analysis

The First 100 Days: House Health Policy Recap

April 15, 2019

Let me count the ways to 100. 1. Affordable Care Act. 2. Insurance Expansion. 3. Drug Pricing. 4. Surprise Billing. 5… Ok, maybe let me count to four.

ORIGINAL ANALYSIS

prescription-drug

Prescription Drug: Regulation

CMS Issues Pair of Rules on Line Item Extension Drugs

March 29, 2019

CMS issues pair of final rules addressing line item extension drugs.

POST

prescription-drug
Bipartisan Legislation Introduced by Senators Grassley and Klobuchar

Prescription Drug: Legislation

Bipartisan Legislation Introduced by Senators Grassley and Klobuchar

March 19, 2019

The bill would temporarily allow drugs to be imported from certain other countries if facing a shortage or lack of competition.

POST

prescription-drug
Members Send Letter to HHS Opposing Changes to Protected Classes

Prescription Drug: Other

Members Send Letter to HHS Opposing Changes to Protected Classes

March 15, 2019

On March 13, 2019, more than 70 members joined Representatives Barbara Lee (D-CA) and Will Hurd (R-TX) in sending a letter to Secretary and of Health and Human Services Alex Azar expressing opposition to the CMS proposed rule changing the six protected classes of drugs in Medicare Part D.

POST

prescription-drug

Prescription Drug: Other

CMS Updates Drug Spending Dashboards

March 15, 2019

CMS updated its drug spending dashboards with data for 2017.

POST

prescription-drug
Prescription Drug Legislation Considered

Prescription Drug: Legislation

Prescription Drug Legislation Considered

March 15, 2019

House E&C Health Subcommittee holds legislative hearing to examine seven bills related to lowering the cost of prescription drugs.

POST

prescription-drug
President’s FY 2020 Budget Includes Drug Proposals

Prescription Drug: Original Analysis

President’s FY 2020 Budget Includes Drug Proposals

March 13, 2019

The White House FY 2020 budget proposal

POST

prescription-drug

Prescription Drug: Legislation

Accelerated Drug Approval for Prescription Therapies (ADAPT) Act

March 11, 2019

On March 6, 2019, Senator Mike Braun (R-IN) introduced the Accelerated Drug Approval for Prescription Therapies (ADAPT) Act (S. 658), which would create an expedited drug approval process at FDA specifically for drugs that are currently approved for sale in developed countries.

EXTERNAL LINK

prescription-drug

Prescription Drug: Legislation

Drug Price Transparency (DPT) Act

March 11, 2019

On March 6, 2019, Senator Mike Braun (R-IN) introduced the Drug Price Transparency (DPT) Act (S. 657), which would extend the idea of the HHS OIG PBM rebate rule to the commercial insurance market and prohibit PBMs from receiving any rebates or reductions in price from drug manufacturers.

EXTERNAL LINK

prescription-drug

Prescription Drug: Issue Primers

Trump Administration Drug Pricing Blueprint Policies and Proposals Tracker

March 08, 2019

McDermottPlus’ American Patients First: The Trump Administration Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs Policies and Proposals Tracker

POST

prescription-drug

Prescription Drug: Legislation

The Medicare Negotiation and Competitive Licensing Act (S. 377)

February 07, 2019

POST

prescription-drug

Prescription Drug: Legislation

The Medicare Negotiation and Competitive Licensing Act (H.R. 1046)

February 07, 2019

POST

prescription-drug

Prescription Drug: Pricing , Regulation

Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses

January 25, 2019

EXTERNAL LINK

prescription-drug

Prescription Drug: Legislation

The Medicare Drug Price Negotiation Act (S. 99)

January 10, 2019

POST

prescription-drug

Prescription Drug: Legislation

The Medicare Drug Price Negotiation Act (H.R. 448)

January 10, 2019

POST

prescription-drug

Prescription Drug: Legislation

Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 (S. 62)

January 09, 2019

POST

prescription-drug

Prescription Drug: Legislation

Medicare Prescription Drug Price Negotiation Act of 2019

January 08, 2019

POST

prescription-drug

Prescription Drug: Original Analysis

Court Issues Permanent Injunction Blocking Medicare 340B Payment Cuts

December 27, 2018

POST

prescription-drug

Prescription Drug: Regulation

Ceiling Price Effective Date

November 30, 2018

EXTERNAL LINK

prescription-drug

Prescription Drug: Original Analysis

Administration Offers Up New Proposals to Cut Drug Costs

November 26, 2018

POST

prescription-drug

Prescription Drug: Original Analysis

CMS Requests Comment on Potential IPI Model for Part B Drugs

October 25, 2018

POST

prescription-drug

Prescription Drug: Pricing , Regulation

ANPRM IPI Model for Medicare Part B Drugs

October 25, 2018

EXTERNAL LINK

prescription-drug

Prescription Drug: Pricing , Regulation

Regulation to Require Drug Pricing Transparency

October 18, 2018

EXTERNAL LINK

prescription-drug

Prescription Drug: Original Analysis

White House Builds Momentum for Drug Price Controls

May 21, 2018

POST

prescription-drug

Prescription Drug: Guidance

American Patients First Blueprint

May 01, 2018

EXTERNAL LINK

Load more
beakernav X1E2BFA62-BFCE-43C1-B777-27E3E5216018medical bagoriginal analysis +external linkpdf downloadstethoscope